- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
Nathalie Pierrepont finds that what retailers think are back-to-school "must haves" are really a waste of money.
Investors gave up on SodaStream - worried that it was just a fad. The latest earnings, however are effervescent.
TheStreet interviewed New Yorkers about the effectiveness of Facebook advertisements.